Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New ProspectsAntonio Rampino, Jean‐Martin Beaulieu, Aleksandra Marakhovskaia et al.|Frontiers in Psychiatry|2019Cited by 70
Evidence of an interaction between <i>FXR1</i> and <i>GSK3β</i> polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychoticsAntonio Rampino, Giuseppe Blasi, Rita Masellis et al.|European Psychiatry|2021Cited by 8
M207. REVEALING HYPOTHALAMIC PATHWAYS CONTRIBUTION TO OLANZAPINE- INDUCED METABOLIC SYNDROME: FROM MURINE MODEL TO HUMAN TRANSLATIONFederica Veneziani, Jean‐Martin Beaulieu, Antonio Rampino et al.|Schizophrenia Bulletin|2020Cited by 0
P.477 Exploring the mechanism of olanzapine induced metabolic syndrome: from murine model validation to behavioral and physiological investigationFederica Veneziani, Jean‐Martin Beaulieu, Marco Zezza et al.|European Neuropsychopharmacology|2020Cited by 0
Olanzapine- induced metabolic syndrome pathogenesis: Hypothalamic “leptin resistance” or “pomc resistance”?Federica Veneziani, Jean‐Martin Beaulieu, Marco Zezza et al.|European Psychiatry|2021Cited by 0